Mitochondrial-targeted cyclometalated Ir(III)-5,7-dibromo/dichloro-2-methyl-8-hydroxyquinoline complexes and their anticancer efficacy evaluation in Hep-G2 cells
Metallomics · 2024
DOI: 10.1093/mtomcs/mfae032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metallomics, 2024. Verfasst von Ting Meng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Pharmaceutical College, Guangxi Medical University, Nanning Guangxi, China. Hauptthemen laut MEDLINE: Iridium, Antineoplastic Agents, Mitochondria. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Both 8-hydroxyquinoline compounds and iridium (Ir) complexes have emerged as potential novel agents for tumor therapy. In this study, we synthesized and characterized two new Ir(III) complexes, [Ir(L1)(bppy)2] (Br-Ir) and [Ir(L2)(bppy)2] (Cl-Ir), with 5,7-dibromo-2-methyl-8-hydroxyquinoline (HL-1) or 5,7-dichloro-2-methyl-8-hydroxyquinoline as the primary ligand. Complexes Br-Ir and Cl-Ir successfully inhibited antitumor activity in Hep-G2 cells. In addition, complexes Br-Ir and Cl-Ir were localized in the mitochondrial membrane and caused mitochondrial damage, autophagy, and cellular immunity in Hep-G2 cells. We tested the proteins related to mitochondrial and mitophagy by western blot analysis, which showed that they triggered mitophagy-mediated apoptotic cell death. Remarkably, complex Br-Ir showed high in vivo antitumor activity, and the tumor growth inhibition rate was 63.0% (P < 0.05). In summary, our study on complex Br-Ir revealed promising results in in vitro and in vivo antitumor activity assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Pharmaceutical College, Guangxi Medical University, Nanning Guangxi, China.
- Guangxi Engineering Center in Biomedical Material for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning Guangxi, China.
- State Key Laboratory of Pharmaceutical Biotechnology, Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing Ji…
Förderung
- Natural Science Foundation of Guangxi Province
- National Natural Science Foundation of China
Zitieren
APA
Meng, T., Shi, X., Chen, H., Xu, Z., Qin, W., Wei, K., Yang, X., Huang, J., & Liao, C. (2024). Mitochondrial-targeted cyclometalated Ir(III)-5,7-dibromo/dichloro-2-methyl-8-hydroxyquinoline complexes and their anticancer efficacy evaluation in Hep-G2 cells. Metallomics. https://doi.org/10.1093/mtomcs/mfae032
Vancouver
Meng T, Shi X, Chen H, Xu Z, Qin W, Wei K, et al. Mitochondrial-targeted cyclometalated Ir(III)-5,7-dibromo/dichloro-2-methyl-8-hydroxyquinoline complexes and their anticancer efficacy evaluation in Hep-G2 cells. Metallomics. 2024. doi:10.1093/mtomcs/mfae032
BibTeX
@article{Meng2024,
author = {Meng, Ting and Shi, Xiongzhi and Chen, Hongfen and Xu, Zhong and Qin, Weirong and Wei, Kehua and Yang, Xin and Huang, Jin and Liao, Chuanan},
title = {Mitochondrial-targeted cyclometalated Ir(III)-5,7-dibromo/dichloro-2-methyl-8-hydroxyquinoline complexes and their anticancer efficacy evaluation in Hep-G2 cells},
journal = {Metallomics},
year = {2024},
doi = {10.1093/mtomcs/mfae032}
}
EUVIMED